Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Kinoshita, Ryo ; Arashiro, Takeshi ; Kitamura, Noriko ; Arai, Satoru ; Takahashi, Koki ; Suzuki, Tadaki ; Suzuki, Motoi ; Yoneoka, Daisuke
• Description:
  A nationwide survey of SARS-CoV-2 antinucleocapsid seroprevalence among blood donors in Japan revealed that, as of November 2022, infection-induced seroprevalence of the population was 28.6% (95% CI 27.6%-29.6%). Seroprevalence studies might complement routine surveillance and ongoing monitoring efforts to provide a more complete real-time picture of COVID-19 burden.
• Subjects:
  Antibodies, Viral Blood Donors COVID-19 Humans SARS-CoV-2 Seroepidemiologic Studies
• Keywords:
  Japan Respiratory Infections Seroepidemiology Seroprevalence Surveillance Viruses Zoonoses
• Source:
  Emerg Infect Dis. 2023; 29(9):1868-1871
• Pubmed ID:
  37506681
• Pubmed Central ID:
  PMC10461656
• Document Type:
  Journal Article
• Genre:
  Dispatch
• Place as Subject:
  Japan
• Volume:
  29
• Issue:
  9
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:389ec1bd7b3b0776e2535bbfe2c4c9c56e492cbbf0d03417c7ea1d94bc42bcb4
• Download URL:
  https://stacks.cdc.gov/view/cdc/133580/cdc_133580_DS1.pdf
• File Type:
  [PDF - 1.28 MB ]